TRAIL is a potent inducer of apoptosis in most cancer cells, but not in normal cells, and therefore has deserved intense interest as a promising agent for cancer therapy. In the search for bioactive natural products for overcoming TRAIL-resistance, we previously reported a number of active compounds. In our screening program on natural resources targeting overcoming TRAIL-resistance, activity-guided fractionation of the MeOH extract of Datura stramonium leaves led to the isolation of three alkaloids – scopolamine (1), trigonelline (2), and tyramine (3). Compounds 1, 2, and 3 exhibited TRAIL-resistance overcoming activity at 50, 150, and 100 μM, respectively in TRAIL-resistant AGS cells.
TrivediR, MishraDP. (2015) Trailing TRAIL resistance: novel target for TRAIL sensitization in cancer cells. Frontiers in Oncology, 5, 1–20.
2.
IshibashiM, OhtsukiT. (2008) Studies on search for bioactive products targeting TRAIL signaling leading to tumor cell apoptosis. Medicinal Research Review, 28, 688–714.
3.
LemkeJ, KarstedtSV, ZinngrebeJ, WalczakH. (2014) Getting TRAIL back on track for cancer therapy. Cell Death and Differentiation, 21, 1350–1364.
4.
ZhangL, FangB. (2005) Mechanism of resistance to TRAIL-induced apoptosis in cancer. Cancer gene therapy, 12, 228–237.
5.
OhtsukiT, TamakiM, ToumeK, IshibashiM. (2008) A novel sesquiterpenoid dimer parviflorene F induces apoptosis by up-regulating the expression of TRAIL-R2 and a caspase-dependent mechanism. Bioorganic and Medicinal Chemistry, 16, 1756–1763.
6.
HasegawaH, YamadaY, KomiyamaK, HayashiM, IshibashiM, SunazukaT, IzuharaT, SugaharaK, TsurudaK, MasudaM, TakasuN, TsukasakiK, TomonagaM, KamihiraS. (2007) A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through 15-deoxy-Δ12, 14 prostaglandin J2 production. Blood, 110, 1664–1674.
7.
AhmedF, ToumeK, SadhuSK, OhtsukiT, AraiMA, IshibashiM. (2010) Constituents of Amoora cucullata with TRAIL resistance-overcoming activity. Organic and Biomolecular Chemistry, 8, 3696–3703.
8.
ToumeK, HabuT, AraiMA, KoyanoT, KowithayakornT, IshibashiM. (2105) Prenylated flavonoids and resveratrol derivatives isolated from Artocarpus communis with the ability to overcome TRAIL resistance. Journal of Natural Products, 78, 103–110.
9.
KarmakarUK, IshikawaN, ToumeK, AraiMA, SadhuSK, AhmedF, IshibashiM. (2015) Sesquiterpenes with TRAIL-resistance overcoming activity from Xanthium strumarium. Bioorganic and Medicinal Chemistry, 23, 4746–4754.
10.
SoniP, SiddiquiAA, DwivediJ, SoniV. (2012) Pharmacological properties of Datura stramonium L. as a potential medicinal tree: An overview. Asia Pacific Journal of Tropical Biomedicine, 2, 1002–1008.
11.
SanjitaD, KumarP, BasuSP. (2012) Phytoconstituents and therapeutic potentials of Datura stramonium Linn. Journal of Drug Delivery and Therapeutics, 2, 4–7.
12.
MunozMA, Joseph-NathanP. (2010) DFT-GIAO 1H NMR chemical shift prediction for the spectral assignment and conformational analysis of the anticholinergic drugs (-)-scopolamine and (-)-hyoscyamine. Magnetic Resonance in Chemistry, 48, 458–463;
13.
GlaserR, ShiftanD. (1999) Conformational pseudopolymorphism and solid-state CPMAS NMR studies for determination of solvent-dependent solution-state conformational preferences for (-)-scopolamine hydrobromide/hydrochloride salts. Journal of Organic Chemistry, 64, 9217–9224.
14.
LiC-Y, LinC-H, WuT-S. (2005) Quantitative analysis of camptothecin derivatives in Nothapodytes foetida using 1H-NMR method. Chemical and Pharmaceutical Bulletin, 53, 347–349.
15.
ElgorashiEE, DrewesSE, van StadenJ. (2001) Alkaloids from Crinum moorei. Phytochemistry, 56, 637–340.
16.
ShahwarD, RazaMA, RehmanS-U, KhanT. (2011) Evaluation of acetylcholine esterase and protease inhibitory activity of scopolamine extracted from Datura innoxia. Asian Journal of Chemistry, 23, 1783–1785.
17.
SchonK, AtriA, HasselmoME, TricaricoMD, LoPrestiML, SternCE. (2005) Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in human. The Journal of Neuroscience, 25, 9112–9123.
18.
ZhouJ, ZhouS, ZengS. (2013) Experimental diabetes treated with trigonelline: effect on β cell and pancreatic oxidative parameters. Fundamental and Clinical Pharmacology, 27, 279–287.
19.
HirakawaN, OkauchiR, MiuraY, YagasakiK. (2005) Anti-invasive activity of niacin and trigonelline against cancer cell. Bioscience, Biotechnology, and Biochemistry, 69, 653–658.
20.
TohdaC, NakamuraN, KomatsuK, HattoriM. (1999) Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells. Biological and Pharmaceutical Bulletin, 22, 679–682.
21.
VarmaDR, DengX-F, ChemtobS, NantelF, BouvierM. (1995) Characterization of the vasorelaxant activity of tyramine and other phenylethylamines in rat aorta. Canadian Journal of Physiology and Pharmacology, 73, 742–746.
22.
JamiesonDD, TaylorKM. (1979) Non-specific stimulant activity of tyramine on isolated intestinal preparation. Agents and actions, 9, 422–427.
